Question 1

What is Keytruda (pembrolizumab)?

Accepted Answer

Keytruda (pembrolizumab) is a humanized monoclonal antibody used in cancer immunotherapy to treat melanoma, lung, head‑and‑neck, Hodgkin lymphoma, stomach, cervical and certain breast cancers, administered via intravenous infusion.

Question 2

How many companies research Keytruda (pembrolizumab)?

Accepted Answer

Based on our data, 36 companies research Keytruda (pembrolizumab). This number is updated daily as we discover new companies through job posting analysis.

Question 3

What types of companies research Keytruda (pembrolizumab)?

Accepted Answer

Keytruda (pembrolizumab) is relevant across multiple industries including Biotechnology Research, Pharmaceutical Manufacturing, Hospitals and Health Care. Companies range from startups to enterprises with 10,000+ employees.

Question 4

How does TheirStack track companies related to Keytruda (pembrolizumab)?

Accepted Answer

TheirStack analyzes millions of job postings daily from company career pages, job boards, and recruitment platforms. When a company mentions Keytruda (pembrolizumab) in their job descriptions, requirements, or responsibilities, we identify them as related to Keytruda (pembrolizumab) and add them to our database.

Question 5

How can I get the full list of companies that research Keytruda (pembrolizumab)?

Accepted Answer

You can access the complete list of 36 companies on TheirStack. The data includes company name, industry, size, location, funding, and revenue. Available via our web app or API.

Question 6

How often is the company data updated?

Accepted Answer

Our database is refreshed daily. We continuously monitor job postings to detect new companies researching Keytruda (pembrolizumab) and update existing records.

Company	Country	Industry	Employees	Revenue	Technologies
Summit Therapeutics, Inc.	United States	Biotechnology Research	350		Keytruda (pembrolizumab)
The START Center for Cancer Research	United States	Biotechnology Research	261		Keytruda (pembrolizumab)
Precision Medicine Group	United States	Pharmaceutical Manufacturing	3.4k	$15M	Keytruda (pembrolizumab)
Humanitas	Italy	Hospitals and Health Care	5.9k		Keytruda (pembrolizumab)
PRECISIONheor	United States	Business Consulting and Services	97	$18M	Keytruda (pembrolizumab)
Memorial Sloan Kettering Cancer Center	United States	Hospitals and Health Care	21k	$5.5B	Keytruda (pembrolizumab)
Region Sjælland	Denmark	Government Administration	10k		Keytruda (pembrolizumab)
Radboudumc	Netherlands	Hospitals and Health Care	10k	$3.8M	Keytruda (pembrolizumab)
OneOncology	United States	Hospitals and Health Care	1k	$4.2M	Keytruda (pembrolizumab)
Investissement Québec	Canada	Financial Services	1.3k		Keytruda (pembrolizumab)

Companies researching Keytruda (pembrolizumab)

List of companies that research Keytruda (pembrolizumab)